Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BASE
4476
DELISTED
Couchbase
BASE
| $1.15M | ﹤0.01% |
+36,945
| New | +$1.36M |
|
4477
AEye
LIDR
$52.3M
| $1.15M | ﹤0.01% |
7,001
+5,080
| +264% | +$1.41M |
|
4478
CALL
Alight
ALIT
$517M
| $1.15M | ﹤0.01% |
+5,000
| New | +$1.05M |
|
4479
Caledonia Mining Corp
CMCL
$363M
| $1.15M | ﹤0.01% |
94,859
-67,777
| -42% | -$823K |
|
|
GGPIU
4480
DELISTED
Gores Guggenheim, Inc. Unit
GGPIU
| $1.15M | ﹤0.01% |
107,701
-2,452,537
| -96% | -$25.3M |
|
|
PRO
4481
DELISTED
PROS Holdings
PRO
| $1.15M | ﹤0.01% |
32,311
+1,545
| +5% | +$64.9K |
|
4482
Hawkins
HWKN
$2.76B
| $1.15M | ﹤0.01% |
32,833
+17,520
| +114% | +$606K |
|
4483
SeaStar Medical
ICU
$12.8M
| $1.15M | ﹤0.01% |
456
+90
| +25% | +$223K |
|
|
K
4484
PUT
DELISTED
Kellanova
K
| $1.14M | ﹤0.01% |
19,064
| – | – |
|
|
LDTC
4485
DELISTED
LeddarTech
LDTC
| $1.14M | ﹤0.01% |
233,998
-1,533,514
| -87% | -$7.44M |
|
|
RDUS
4486
DELISTED
Radius Recycling
RDUS
| $1.14M | ﹤0.01% |
26,046
-94,867
| -78% | -$4.59M |
|
|
EUCR
4487
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
| $1.14M | ﹤0.01% |
116,623
+80,000
| +218% | +$780K |
|
|
PTVE
4488
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $1.14M | ﹤0.01% |
90,765
-90,260
| -50% | -$1.22M |
|
|
ACHL
4489
DELISTED
Achilles Therapeutics
ACHL
| $1.13M | ﹤0.01% |
145,529
-50,615
| -26% | -$333K |
|
4490
Cato Corp
CATO
$69.3M
| $1.13M | ﹤0.01% |
68,475
+27,332
| +66% | +$457K |
|
|
NFJ
4491
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.42B
| $1.13M | ﹤0.01% |
+76,411
| New | +$1.17M |
|
|
MEOAU
4492
DELISTED
Minority Equality Opportunities Acquisition Inc. Units
MEOAU
| $1.13M | ﹤0.01% |
+110,000
| New | +$1.12M |
|
|
CZOO
4493
CALL
DELISTED
Cazoo Group Ltd
CZOO
| $1.13M | ﹤0.01% |
222
-45
| -17% | -$844K |
|
|
CNTQU
4494
DELISTED
Chardan NexTech Acquisition 2 Corp. Unit
CNTQU
| $1.13M | ﹤0.01% |
+110,000
| New | +$1.12M |
|
4495
Liberty Latin America Class C
LILAK
$1.67B
| $1.13M | ﹤0.01% |
94,454
-138,053
| -59% | -$1.71M |
|
4496
Greif
GEF
$4.93B
| $1.13M | ﹤0.01% |
17,430
-1,124
| -6% | -$69.6K |
|
|
FSRXU
4497
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
| $1.13M | ﹤0.01% |
114,253
-292,094
| -72% | -$2.9M |
|
4498
Resources Connection
RGP
$153M
| $1.12M | ﹤0.01% |
+71,207
| New | +$1.07M |
|
4499
Clear Secure
YOU
$5.57B
| $1.12M | ﹤0.01% |
27,377
-262,571
| -91% | -$12.3M |
|
4500
PUT
Corning
GLW
$126B
| $1.12M | ﹤0.01% |
30,700
+10,600
| +53% | +$423K |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.